OCT 30, 2026 · JOURNAL ARTICLE
Coverage Criteria vs. Clinical Reality: Navigating Medicaid Barriers to Tirzepatide Access
Journal of Health Care for the Poor and Underserved
Abstract: Medicaid beneficiaries often face barriers to accessing evidence-based metabolic therapies, even as U.S. Food and Drug Administration (FDA) indications for agents such as